
Mitragotri's work bridges advanced drug development and skin care for tailored treatments.
Samir Mitragotri, PhD, is a professor of bioengineering at Harvard University and the founder of CAGE Bio

Mitragotri's work bridges advanced drug development and skin care for tailored treatments.

Advancements in therapeutic agents demand innovative strategies for safe, localized skin treatments, Mitragotri argues.

Mitragotri said new innovations like ionic liquid-based delivery systems can offer better treatment for immunodermatological conditions.

The innovative technology is unlocking new possibilities in dermatology by improving the solubility and permeability of drugs for topical use.